Source link : https://newshealth.biz/health-news/il-6-inhibitor-shows-promise-in-diabetic-macular-edema/
DENVER — Targeting an inflammatory pathway in diabetic macular edema (DME), in addition to angiogenesis, led to greater improvement in visual acuity and retinal anatomy, a randomized trial showed. Single-agent ranibizumab (Lucentis) improved best corrected visual acuity (BCVA) by 9.4 letters at 44-48 weeks, which increased to 12.8 letters with the addition of the interleukin […]
The post IL-6 Inhibitor Shows Promise in Diabetic Macular Edema first appeared on News Health.
—-
Author : News Health
Publish date : 2026-05-06 19:39:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8